Prevymis (letermovir) - Merck (MSD)
Impact of Letermovir for CMV Prophylaxis in Chinese kidney transplant patients (ChiCTR) - Jan 31, 2026 - P4 | N=100 | Recruiting | Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University; The First Affiliated Hospital of Xi'an Jiaotong University | Not yet recruiting ➔ Recruiting 
Enrollment open • Transplantation
https://www.chictr.org.cn/showproj.html?proj=281754
 
Jan 31, 2026
 
Prev Next